Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
Published September 6, 2023 · Recall initiated: August 23, 2023
Summary
FDA records drug Class III recall D-1139-2023, published September 6, 2023 and initiated August 23, 2023. Recalling firm: Contract Pharmaceuticals Limited Canada; Status: Terminated; Reported quantity: 11,350 bottles; Lot: Lot # 118920, exp. January 2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: slow leakage under the cap
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Contract Pharmaceuticals Limited Canada
- Distributor
- Nationwide in the USA.
- Lot
- Lot # 118920, exp. January 2024.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAClindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: MarlexMarch 13, 2024
- FDAClindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse PharmaceuticalsMarch 13, 2024
- FDAdilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%, IV Bag, RX only, Central Admixture Pharmacy Services,September 6, 2023
- FDADIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEXSeptember 6, 2023
- FDAdilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride, IV Bag, Rx Only, Central Admixture PharmacySeptember 6, 2023
- FDADianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FLEX ll Container with yellow pullSeptember 6, 2023
Questions about this recall
Was Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60 recalled?
Yes. FDA published recall D-1139-2023 on September 6, 2023. Reported hazard: Defective Container: slow leakage under the cap
What should I do if I have this product?
Voluntary: Firm initiated · Letter